"Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older with Asthma"
This study is recruiting patients who meet the following conditions:
If you feel you may qualify for the study and would like to find out more, please contact us on 01536 748282. This line is available from 8am-5pm, Monday-Friday (except Bank Holidays)
The above list is an example of some of the key criteria required to participate in the study and meeting these conditions does not guarantee a place on the trial. For more information, please contact the research team.